• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aptorum Group Limited - Class A Ordinary Shares (NQ:APM)

1.020 -0.100 (-8.93%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Aptorum Group Limited - Class A Ordinary Shares

< Previous 1 2 3 Next >
News headline image
Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania
March 10, 2026
From Aptorum Group Ltd
Via GlobeNewswire
News headline image
Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
March 06, 2026
From Aptorum Group Ltd
Via GlobeNewswire
News headline image
Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB’s Automated APOE Testing Platform for Alzheimer’s Disease
February 02, 2026
From Aptorum Group Ltd
Via GlobeNewswire
Aptorum Group Ltd. (NASDAQ: APM) Leading the Way in Wednesday Trading Based on Percentage Gain
March 06, 2024
Via Investor Brand Network
Aptorum Group Ltd. (NASDAQ: APM) Leading the Way in Friday Trading Based on Percentage Gain
August 25, 2023
Via Investor Brand Network
News headline image
DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer’s Disease (CTAD) 2025 Conference
November 19, 2025
From Aptorum Group Ltd
Via GlobeNewswire
News headline image
Aptorum Group Limited Announces Up To $6 Million Registered Direct Offering
October 10, 2025
From Aptorum Group Ltd
Via GlobeNewswire
News headline image
As part of the planned merger with DiamiR Biosciences, Aptorum Group will expand its board and management team with seasoned executives
October 09, 2025
From Aptorum Group Ltd
Via GlobeNewswire
News headline image
Aptorum Group and DiamiR Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 05, 2025
From Aptorum Group Ltd
Via GlobeNewswire
News headline image
DiamiR Biosciences and Aptorum Group Announce New York State Approval for DiamiR’s APOE Genotyping Test
August 21, 2025
From Aptorum Group Ltd
Via GlobeNewswire
News headline image
Aptorum Group Limited Regains Compliance with NASDAQ’s Minimum Bid Price Requirement
August 04, 2025
From Aptorum Group Ltd
Via GlobeNewswire
News headline image
Aptorum Group Limited and DiamiR Biosciences Enter into Definitive Merger Agreement
July 16, 2025
From Aptorum Group Ltd
Via GlobeNewswire
News headline image
Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
April 16, 2025
From Aptorum Group Ltd
Via GlobeNewswire
News headline image
Aptorum Group Limited Announces Pricing of $3.0 Million Registered Direct Offering
January 02, 2025
From Aptorum Group Ltd
Via GlobeNewswire
News headline image
Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2024
December 20, 2024
From Aptorum Group Limited
Via Business Wire
News headline image
Aptorum Group Limited Reports 2023 Fiscal Year End Financial Results and Provides Business Update
April 30, 2024
From Aptorum Group Limited
Via Business Wire
Aptorum Group Ltd. (NASDAQ: APM) is One of Thursday Morning’s Most Active Stocks
March 14, 2024
Via Investor Brand Network
News headline image
Aptorum Group Ltd Announces Entering into an Agreement and Plan of Merger with YOOV Group Holding Ltd and a Split-off Agreement to Separate its Legacy Business
March 06, 2024
From Aptorum Group Limited
Via Business Wire
News headline image
Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2023
December 22, 2023
From Aptorum Group Limited
Via Business Wire
News headline image
Aptorum Group Limited Announces Results of 2023 Annual General Meeting of Shareholders
December 21, 2023
From Aptorum Group Limited
Via Business Wire
News headline image
Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 20, 2023
November 16, 2023
From Aptorum Group Limited
Via Business Wire
News headline image
Aptorum Group Receives Nasdaq Approval to Transfer Listing to Nasdaq Capital Markets
August 10, 2023
From Aptorum Group Limited
Via Business Wire
News headline image
Aptorum Group Updates on a Phase 1b/2a Clinical Trial for Repurposed Small Molecule Drug SACT-1 for Neuroblastoma
June 22, 2023
From Aptorum Group Limited
Via Business Wire
News headline image
Aptorum Group Limited Announces Voluntary Delisting from Euronext Paris
June 09, 2023
From Aptorum Group Limited
Via Business Wire
News headline image
Aptorum Group Receives Nasdaq Notification of Minimum Stockholders’ Equity Deficiency
May 05, 2023
From Aptorum Group Limited
Via Business Wire
News headline image
Aptorum Therapeutics Limited Enters Into Letter of Intent and Term Sheet with Universal Sequencing Technology Corporation to Merge with Aptorum Group’s Subsidiary Paths Innovations Limited
May 01, 2023
From Aptorum Group Limited
Via Business Wire
News headline image
Aptorum Group Limited Reports 2022 Fiscal Year End Financial Results and Provides Business Update
April 28, 2023
From Aptorum Group
Via Business Wire
News headline image
Aptorum Group Enters into Letter of Intent and Term Sheet To Acquire U Group
March 27, 2023
From Aptorum Group Limited
Via Business Wire
News headline image
Aptorum Group Limited and ASP Isotopes Inc. Interviews to Air on Bloomberg U.S. on the RedChip Money Report(R)
March 17, 2023
Via ACCESSWIRE
News headline image
Aptorum Group Announces Completion of Pre-IND Discussions with US FDA on its ALS-4, a First-in-Class Small Molecule Drug Targeting Methicillin Resistant Staphylococcus Aureus
March 03, 2023
From Aptorum Group Limited
Via Business Wire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap